Clinical Trials at Ospedale Umberto I
During the past decade, Ospedale Umberto I conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ospedale Umberto I" #1 sponsor was "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 3 trials, followed by "National Cancer Institute, Naples" with 3 trials
sponsored, "European Institute of Oncology" with 2 trials sponsored, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Umberto I"
#1 collaborator was "Averion International Corporation" with 1 trials as a collaborator, "Cattedra di Endocrinochirurgia, Università di Verona" with 1 trials as a collaborator, "Clinical Research Technology S.r.l." with 1 trials as a collaborator, "Federation of Italian Cooperative Oncology Groups" with 1 trials as a collaborator and "Fondazione Policlinico Universitario Agostino Gemelli IRCCS" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at Ospedale Umberto I
According to Clinical.Site data, the most researched conditions in "Ospedale Umberto I" are
"Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Non-small Cell Lung Cancer Stage IIIB" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Ospedale Umberto I" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Umberto I
Most popular intervention types in "Ospedale Umberto I" are "Drug" (20 trials), "Other" (2 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (3 trials), "cisplatin" (3 trials), "Cisplatin" (2 trials), "Anastrozole or Letrozole or Exemestane" (1 trials) and "Antibiotic" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Umberto I
The vast majority of trials in "Ospedale Umberto I" are
14 trials for "All" genders and 7 trials for "Female" genders.
Clinical Trials Status at Ospedale Umberto I
Currently, there are NaN active trials in "Ospedale Umberto I".
undefined are not yet recruiting,
2 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Ospedale Umberto I,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Umberto I, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".